The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Muscle Pain Treatment Market Research Report 2025
Synopsis
The global Muscle Pain Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Muscle Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Muscle Pain Treatment.
Report Scope
The Muscle Pain Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Muscle Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Muscle Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Voltarol
Baxter International Inc.
Teva Pharmaceutical Industries Ltd.
Eli Lilly
Pfizer
Johnson & Johnson
Purdue Pharma
Endo Pharmaceuticals Plc.
Forest Laboratories Inc.
GlaxoSmithKline Plc.
F. Hoffmann-La Roche Ltd.
Segment by Type
Medical Treatement
Physiotherapy
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Muscle Pain Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Muscle Pain Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Muscle Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Muscle Pain Treatment.
Report Scope
The Muscle Pain Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Muscle Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Muscle Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Voltarol
Baxter International Inc.
Teva Pharmaceutical Industries Ltd.
Eli Lilly
Pfizer
Johnson & Johnson
Purdue Pharma
Endo Pharmaceuticals Plc.
Forest Laboratories Inc.
GlaxoSmithKline Plc.
F. Hoffmann-La Roche Ltd.
Segment by Type
Medical Treatement
Physiotherapy
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Muscle Pain Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Muscle Pain Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medical Treatement
1.2.3 Physiotherapy
1.3 Market by Application
1.3.1 Global Muscle Pain Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Muscle Pain Treatment Market Perspective (2019-2030)
2.2 Muscle Pain Treatment Growth Trends by Region
2.2.1 Global Muscle Pain Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Muscle Pain Treatment Historic Market Size by Region (2019-2024)
2.2.3 Muscle Pain Treatment Forecasted Market Size by Region (2025-2030)
2.3 Muscle Pain Treatment Market Dynamics
2.3.1 Muscle Pain Treatment Industry Trends
2.3.2 Muscle Pain Treatment Market Drivers
2.3.3 Muscle Pain Treatment Market Challenges
2.3.4 Muscle Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Muscle Pain Treatment Players by Revenue
3.1.1 Global Top Muscle Pain Treatment Players by Revenue (2019-2024)
3.1.2 Global Muscle Pain Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Muscle Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Muscle Pain Treatment Revenue
3.4 Global Muscle Pain Treatment Market Concentration Ratio
3.4.1 Global Muscle Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Muscle Pain Treatment Revenue in 2023
3.5 Muscle Pain Treatment Key Players Head office and Area Served
3.6 Key Players Muscle Pain Treatment Product Solution and Service
3.7 Date of Enter into Muscle Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Muscle Pain Treatment Breakdown Data by Type
4.1 Global Muscle Pain Treatment Historic Market Size by Type (2019-2024)
4.2 Global Muscle Pain Treatment Forecasted Market Size by Type (2025-2030)
5 Muscle Pain Treatment Breakdown Data by Application
5.1 Global Muscle Pain Treatment Historic Market Size by Application (2019-2024)
5.2 Global Muscle Pain Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Muscle Pain Treatment Market Size (2019-2030)
6.2 North America Muscle Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Muscle Pain Treatment Market Size by Country (2019-2024)
6.4 North America Muscle Pain Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Muscle Pain Treatment Market Size (2019-2030)
7.2 Europe Muscle Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Muscle Pain Treatment Market Size by Country (2019-2024)
7.4 Europe Muscle Pain Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Muscle Pain Treatment Market Size (2019-2030)
8.2 Asia-Pacific Muscle Pain Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Muscle Pain Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Muscle Pain Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Muscle Pain Treatment Market Size (2019-2030)
9.2 Latin America Muscle Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Muscle Pain Treatment Market Size by Country (2019-2024)
9.4 Latin America Muscle Pain Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Muscle Pain Treatment Market Size (2019-2030)
10.2 Middle East & Africa Muscle Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Muscle Pain Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Muscle Pain Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Voltarol
11.1.1 Voltarol Company Detail
11.1.2 Voltarol Business Overview
11.1.3 Voltarol Muscle Pain Treatment Introduction
11.1.4 Voltarol Revenue in Muscle Pain Treatment Business (2019-2024)
11.1.5 Voltarol Recent Development
11.2 Baxter International Inc.
11.2.1 Baxter International Inc. Company Detail
11.2.2 Baxter International Inc. Business Overview
11.2.3 Baxter International Inc. Muscle Pain Treatment Introduction
11.2.4 Baxter International Inc. Revenue in Muscle Pain Treatment Business (2019-2024)
11.2.5 Baxter International Inc. Recent Development
11.3 Teva Pharmaceutical Industries Ltd.
11.3.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.3.3 Teva Pharmaceutical Industries Ltd. Muscle Pain Treatment Introduction
11.3.4 Teva Pharmaceutical Industries Ltd. Revenue in Muscle Pain Treatment Business (2019-2024)
11.3.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Muscle Pain Treatment Introduction
11.4.4 Eli Lilly Revenue in Muscle Pain Treatment Business (2019-2024)
11.4.5 Eli Lilly Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Muscle Pain Treatment Introduction
11.5.4 Pfizer Revenue in Muscle Pain Treatment Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Muscle Pain Treatment Introduction
11.6.4 Johnson & Johnson Revenue in Muscle Pain Treatment Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Purdue Pharma
11.7.1 Purdue Pharma Company Detail
11.7.2 Purdue Pharma Business Overview
11.7.3 Purdue Pharma Muscle Pain Treatment Introduction
11.7.4 Purdue Pharma Revenue in Muscle Pain Treatment Business (2019-2024)
11.7.5 Purdue Pharma Recent Development
11.8 Endo Pharmaceuticals Plc.
11.8.1 Endo Pharmaceuticals Plc. Company Detail
11.8.2 Endo Pharmaceuticals Plc. Business Overview
11.8.3 Endo Pharmaceuticals Plc. Muscle Pain Treatment Introduction
11.8.4 Endo Pharmaceuticals Plc. Revenue in Muscle Pain Treatment Business (2019-2024)
11.8.5 Endo Pharmaceuticals Plc. Recent Development
11.9 Forest Laboratories Inc.
11.9.1 Forest Laboratories Inc. Company Detail
11.9.2 Forest Laboratories Inc. Business Overview
11.9.3 Forest Laboratories Inc. Muscle Pain Treatment Introduction
11.9.4 Forest Laboratories Inc. Revenue in Muscle Pain Treatment Business (2019-2024)
11.9.5 Forest Laboratories Inc. Recent Development
11.10 GlaxoSmithKline Plc.
11.10.1 GlaxoSmithKline Plc. Company Detail
11.10.2 GlaxoSmithKline Plc. Business Overview
11.10.3 GlaxoSmithKline Plc. Muscle Pain Treatment Introduction
11.10.4 GlaxoSmithKline Plc. Revenue in Muscle Pain Treatment Business (2019-2024)
11.10.5 GlaxoSmithKline Plc. Recent Development
11.11 F. Hoffmann-La Roche Ltd.
11.11.1 F. Hoffmann-La Roche Ltd. Company Detail
11.11.2 F. Hoffmann-La Roche Ltd. Business Overview
11.11.3 F. Hoffmann-La Roche Ltd. Muscle Pain Treatment Introduction
11.11.4 F. Hoffmann-La Roche Ltd. Revenue in Muscle Pain Treatment Business (2019-2024)
11.11.5 F. Hoffmann-La Roche Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Muscle Pain Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medical Treatement
Table 3. Key Players of Physiotherapy
Table 4. Global Muscle Pain Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Muscle Pain Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Muscle Pain Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Muscle Pain Treatment Market Share by Region (2019-2024)
Table 8. Global Muscle Pain Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Muscle Pain Treatment Market Share by Region (2025-2030)
Table 10. Muscle Pain Treatment Market Trends
Table 11. Muscle Pain Treatment Market Drivers
Table 12. Muscle Pain Treatment Market Challenges
Table 13. Muscle Pain Treatment Market Restraints
Table 14. Global Muscle Pain Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Muscle Pain Treatment Market Share by Players (2019-2024)
Table 16. Global Top Muscle Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Pain Treatment as of 2023)
Table 17. Ranking of Global Top Muscle Pain Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Muscle Pain Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Muscle Pain Treatment Product Solution and Service
Table 21. Date of Enter into Muscle Pain Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Muscle Pain Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Muscle Pain Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Muscle Pain Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Muscle Pain Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Muscle Pain Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Muscle Pain Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Muscle Pain Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Muscle Pain Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Muscle Pain Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Muscle Pain Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Muscle Pain Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Muscle Pain Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Muscle Pain Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Muscle Pain Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Muscle Pain Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Muscle Pain Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Muscle Pain Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Muscle Pain Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Muscle Pain Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Muscle Pain Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Muscle Pain Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Muscle Pain Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Muscle Pain Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Voltarol Company Detail
Table 47. Voltarol Business Overview
Table 48. Voltarol Muscle Pain Treatment Product
Table 49. Voltarol Revenue in Muscle Pain Treatment Business (2019-2024) & (US$ Million)
Table 50. Voltarol Recent Development
Table 51. Baxter International Inc. Company Detail
Table 52. Baxter International Inc. Business Overview
Table 53. Baxter International Inc. Muscle Pain Treatment Product
Table 54. Baxter International Inc. Revenue in Muscle Pain Treatment Business (2019-2024) & (US$ Million)
Table 55. Baxter International Inc. Recent Development
Table 56. Teva Pharmaceutical Industries Ltd. Company Detail
Table 57. Teva Pharmaceutical Industries Ltd. Business Overview
Table 58. Teva Pharmaceutical Industries Ltd. Muscle Pain Treatment Product
Table 59. Teva Pharmaceutical Industries Ltd. Revenue in Muscle Pain Treatment Business (2019-2024) & (US$ Million)
Table 60. Teva Pharmaceutical Industries Ltd. Recent Development
Table 61. Eli Lilly Company Detail
Table 62. Eli Lilly Business Overview
Table 63. Eli Lilly Muscle Pain Treatment Product
Table 64. Eli Lilly Revenue in Muscle Pain Treatment Business (2019-2024) & (US$ Million)
Table 65. Eli Lilly Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Muscle Pain Treatment Product
Table 69. Pfizer Revenue in Muscle Pain Treatment Business (2019-2024) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Johnson & Johnson Company Detail
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Muscle Pain Treatment Product
Table 74. Johnson & Johnson Revenue in Muscle Pain Treatment Business (2019-2024) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Purdue Pharma Company Detail
Table 77. Purdue Pharma Business Overview
Table 78. Purdue Pharma Muscle Pain Treatment Product
Table 79. Purdue Pharma Revenue in Muscle Pain Treatment Business (2019-2024) & (US$ Million)
Table 80. Purdue Pharma Recent Development
Table 81. Endo Pharmaceuticals Plc. Company Detail
Table 82. Endo Pharmaceuticals Plc. Business Overview
Table 83. Endo Pharmaceuticals Plc. Muscle Pain Treatment Product
Table 84. Endo Pharmaceuticals Plc. Revenue in Muscle Pain Treatment Business (2019-2024) & (US$ Million)
Table 85. Endo Pharmaceuticals Plc. Recent Development
Table 86. Forest Laboratories Inc. Company Detail
Table 87. Forest Laboratories Inc. Business Overview
Table 88. Forest Laboratories Inc. Muscle Pain Treatment Product
Table 89. Forest Laboratories Inc. Revenue in Muscle Pain Treatment Business (2019-2024) & (US$ Million)
Table 90. Forest Laboratories Inc. Recent Development
Table 91. GlaxoSmithKline Plc. Company Detail
Table 92. GlaxoSmithKline Plc. Business Overview
Table 93. GlaxoSmithKline Plc. Muscle Pain Treatment Product
Table 94. GlaxoSmithKline Plc. Revenue in Muscle Pain Treatment Business (2019-2024) & (US$ Million)
Table 95. GlaxoSmithKline Plc. Recent Development
Table 96. F. Hoffmann-La Roche Ltd. Company Detail
Table 97. F. Hoffmann-La Roche Ltd. Business Overview
Table 98. F. Hoffmann-La Roche Ltd. Muscle Pain Treatment Product
Table 99. F. Hoffmann-La Roche Ltd. Revenue in Muscle Pain Treatment Business (2019-2024) & (US$ Million)
Table 100. F. Hoffmann-La Roche Ltd. Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Muscle Pain Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Muscle Pain Treatment Market Share by Type: 2023 VS 2030
Figure 3. Medical Treatement Features
Figure 4. Physiotherapy Features
Figure 5. Global Muscle Pain Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Muscle Pain Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Muscle Pain Treatment Report Years Considered
Figure 11. Global Muscle Pain Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Muscle Pain Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Muscle Pain Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Muscle Pain Treatment Market Share by Players in 2023
Figure 15. Global Top Muscle Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Pain Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Muscle Pain Treatment Revenue in 2023
Figure 17. North America Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Muscle Pain Treatment Market Share by Country (2019-2030)
Figure 19. United States Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Muscle Pain Treatment Market Share by Country (2019-2030)
Figure 23. Germany Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Muscle Pain Treatment Market Share by Region (2019-2030)
Figure 31. China Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Muscle Pain Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Muscle Pain Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Muscle Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Voltarol Revenue Growth Rate in Muscle Pain Treatment Business (2019-2024)
Figure 46. Baxter International Inc. Revenue Growth Rate in Muscle Pain Treatment Business (2019-2024)
Figure 47. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Muscle Pain Treatment Business (2019-2024)
Figure 48. Eli Lilly Revenue Growth Rate in Muscle Pain Treatment Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Muscle Pain Treatment Business (2019-2024)
Figure 50. Johnson & Johnson Revenue Growth Rate in Muscle Pain Treatment Business (2019-2024)
Figure 51. Purdue Pharma Revenue Growth Rate in Muscle Pain Treatment Business (2019-2024)
Figure 52. Endo Pharmaceuticals Plc. Revenue Growth Rate in Muscle Pain Treatment Business (2019-2024)
Figure 53. Forest Laboratories Inc. Revenue Growth Rate in Muscle Pain Treatment Business (2019-2024)
Figure 54. GlaxoSmithKline Plc. Revenue Growth Rate in Muscle Pain Treatment Business (2019-2024)
Figure 55. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Muscle Pain Treatment Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
